Incidence of febrile neutropenia with use of docetaxel plus cyclophosphamide (TC) for breast cancer.

被引：0
|
作者：
Patel, Kiran
Diergaarde, Brenda
Brufsky, Adam
Jankowitz, Rachel Catherine
Lembersky, Barry C.
Rastogi, Priya
Huggins-Puhalla, Shannon Leigh
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e12073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12073
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Intermittent dosing of G-CSF to prevent febrile neutropenia during chemotherapy with docetaxel and cyclophosphamide for early breast cancer
    Harris, S. J.
    White, S. C.
    Taylor, L.
    Siderov, J.
    Thomson, J. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S47 - S47
  • [32] High incidence of febrile neutropenia following adjuvant breast chemotherapy with docetaxel, carboplatin and trastuzumab
    Gilbar, Peter
    McPherson, Ian
    Sorour, Natacha
    Sanmugarajah, Jasotha
    BREAST CANCER MANAGEMENT, 2014, 3 (04) : 327 - 333
  • [33] Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer.
    Santos, F. N.
    Cruz, M. R.
    Cezana, L.
    Costa, L. A.
    de Azevedo, C. A.
    De Barros, M. J.
    Silva, E.
    Cozario, L. L.
    Alencar, A. M., Jr.
    Fanelli, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer
    Yu, Joanne L.
    Chan, Kelvin
    Kurin, Michael
    Pasetka, Mark
    Kiss, Alex
    Sridhar, Srikala S.
    Warner, Ellen
    BREAST JOURNAL, 2015, 21 (06): : 658 - 664
  • [35] POTENTIAL PREDICTORS OF FEBRILE NEUTROPAENIA IN WOMEN RECEIVING DOCETAXEL CYCLOPHOSPHAMIDE (TC) FOR EARLY BREAST CANCER IN AN ETHNICALLY DIVERSE POPULATION
    Scheinberg, T.
    Asghari, R.
    Harvey, S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 42 - 42
  • [36] Four versus six cycles of docetaxel and cyclophosphamide in early breast cancer.
    Basu, Aparna
    Dabak, Vrushali S.
    Loutfi, Randa
    Ali, Haythem Y.
    Mohammed, Hadi
    Mahmood, Sharmeen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer.
    Shao Zhimin
    Li, Junjie
    Pang, Da
    Wang, Changqing
    Jiang, Jun
    Yang, Suisheng
    Liu, Yunjiang
    Fu, Pei Fen
    Sheng, Yuan
    Zhang, Guojun
    Cao, Liya
    He, Qi
    Cul, Shude
    Wang, Xijing
    Ren, Guosheng
    Li, Xinzheng
    Yu, Shiyou
    Liu, Pengxi
    Xu, Binghe
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] The real-world experience of adjuvant docetaxel and cyclophosphamide (TC) chemotherapy in HER-2 negative breast cancer.
    Mata, Danilo Giffoni M. M.
    Chan, Kelvin K.
    Eisen, Andrea
    Pezo, Rossanna C.
    Menjak, Ines B.
    Trudeau, Maureen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer
    Cousin, Sophie
    Le Rhun, Emilie
    Mailliez, Audrey
    Fournier, Charles
    Bonneterre, Jacques
    BULLETIN DU CANCER, 2012, 99 (7-8) : E75 - E80
  • [40] Timely management of febrile neutropenia in children with cancer.
    Vedi, Aditi
    Cohn, Richard Jules
    Pennington, Victoria
    O'Meara, Matthew
    Stark, Kylie
    Hunstead, Paul
    Londal, Wendy
    Adnum, Kirsten
    Senner, Anne
    Maurice, Lucy
    James, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
12345